{
    "clinical_study": {
        "@rank": "158029", 
        "arm_group": {
            "arm_group_label": "Open Label Injection of NX-1207", 
            "arm_group_type": "Experimental", 
            "description": "Intraprostatic injection of 2.5 mg NX-1207"
        }, 
        "brief_summary": {
            "textblock": "This study is designed to demonstrate the safety and efficacy of a second transrectal\n      intraprostatic injection of NX-1207 given to subjects with Benign Prostatic Hyperplasia\n      (BPH) who previously received an injection of NX-1207 in an earlier U.S. clinical trial of\n      NX-1207."
        }, 
        "brief_title": "Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Benign Prostatic Hyperplasia", 
            "BPH", 
            "Lower Urinary Tract Symptoms (LUTS)", 
            "LUTS", 
            "Enlarged Prostate"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Prostatic Hyperplasia", 
                "Hyperplasia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Be male aged 45 or older.\n\n          -  Sign an informed consent form.\n\n          -  Be in good health.\n\n          -  Received NX-1207 in a previous completed study (other than NX02-0020) or received\n             NX-1207 or placebo in a concurrent U.S. study (NX02-0017 and NX02-0018) and completed\n             their V10 (365 day) visit.\n\n          -  Have Prostate Gland Volume \u2265 25 mL (25 g).\n\n        Exclusion Criteria:\n\n          -  Surgery or minimally invasive surgical therapy (MIST) for treatment of BPH after\n             first NX-1207 injection\n\n          -  Post-void residual urine volume > 200 mL\n\n          -  Presence of a symptomatic median lobe of the prostate\n\n          -  History of use of self-catheterization for urinary retention.\n\n          -  Urinary retention in the previous 12 months.\n\n          -  Prostatitis\n\n          -  Urinary tract infection more than once in the past 12 months\n\n          -  Prostate or bladder cancer.\n\n          -  Prostate-Specific Antigen (PSA) \u2265 10 ng/mL\n\n          -  Poorly controlled diabetes\n\n          -  History or evidence of illness or condition that may interfere with study or endanger\n             subject\n\n          -  Participation in a study of any investigational drug (other than NX-1207) or\n             investigational device within the previous 90 days\n\n          -  Use of specific prescribed medications that may interfere with study or endanger\n             subject"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01846793", 
            "org_study_id": "NX02-0022"
        }, 
        "intervention": {
            "arm_group_label": "Open Label Injection of NX-1207", 
            "description": "2.5 mg NX-1207 in 10 mL saline vehicle", 
            "intervention_name": "NX-1207", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Benign prostatic hyperplasia", 
            "BPH", 
            "Enlarged prostate", 
            "Lower urinary tract symptoms", 
            "LUTS", 
            "LUTS secondary to BPH", 
            "LUTS/BPH", 
            "Benign prostatic obstruction (BPO)", 
            "BPO", 
            "Bladder outlet obstruction", 
            "BOO"
        ], 
        "lastchanged_date": "April 1, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Laguna Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92653"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92120"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aventura", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33180"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naples", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34102"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meridian", 
                        "country": "United States", 
                        "state": "Idaho", 
                        "zip": "83642"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jeffersonville", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "47130"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shreveport", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "71106"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Annapolis", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21401"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21237"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glen Burnie", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21061"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Towson", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21204"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Missoula", 
                        "country": "United States", 
                        "state": "Montana", 
                        "zip": "59808"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brick", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08724"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Garden City", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11530"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43221"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75010"
                    }, 
                    "name": "For information concerning this clinical site, please contact Nymox at 800-936-9669."
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-8 Years Apart", 
        "overall_contact": {
            "email": "info@nymox.com", 
            "last_name": "There will be multiple sites for this clinical trial. For further information contact Nymox at", 
            "phone": "800-936-9669 or at"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Safety parameters as determined by Adverse Events, clinical laboratory test results, vital signs, physical exam and electrocardiogram (ECG).", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "180 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01846793"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Symptomatic improvement as measured by the change in American Urological Association (AUA) Symptom Index from baseline at 90 days. The AUA Symptom Index is a standardized questionnaire that uses seven questions relating to associated BPH symptoms to provide an assessment of symptom severity on a scale from 0 (no symptoms) to 35 (most severe).", 
                "measure": "Symptomatic Improvement", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }, 
            {
                "description": "Change in prostate volume from baseline to 90 days as measured by transrectal ultrasonography", 
                "measure": "Prostate Volume Change", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }, 
            {
                "description": "Change in Urinary Peak Flow (Qmax) from baseline to 90 days as determined by urinary flow-rate recording (uroflowmetry).", 
                "measure": "Change in Urinary Peak Flow", 
                "safety_issue": "No", 
                "time_frame": "90 days."
            }, 
            {
                "description": "Symptomatic improvement as measured by the change in AUA Symptom Index from baseline at 180 days.", 
                "measure": "Symptomatic Improvement", 
                "safety_issue": "No", 
                "time_frame": "180 days"
            }
        ], 
        "source": "Nymox Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nymox Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}